Association of Derived Neutrophil-To-Lymphocyte Ratio With Prognosis of Coronary Heart Disease After PCI

被引:6
|
作者
Liu, Gang-Qiong [1 ]
Zhang, Wen-Jing [1 ]
Shangguan, Jia-Hong
Zhu, Xiao-Dan
Wang, Wei [2 ]
Guo, Qian-Qian [1 ]
Zhang, Jian-Chao [1 ]
Wang, Kai [1 ]
Liu, Zhi-Yu [1 ]
Song, Feng-Hua [1 ]
Fan, Lei [1 ]
Zheng, Ying-Ying [1 ]
Zhang, Jin-Ying [1 ]
机构
[1] Zhengzhou Univ, Dept Cardiol, Key Lab Cardiac Injury & Repair Henan Prov, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Henan Med Assoc, Adm Dept, Zhengzhou, Peoples R China
来源
FRONTIERS IN CARDIOVASCULAR MEDICINE | 2021年 / 8卷
基金
中国国家自然科学基金;
关键词
derived neutrophil-to-lymphocyte ratio; percutaneous coronary intervention; mortality; neutrophil-to-lymphocyte ratio; coronary heart disease; PREDICTIVE-VALUE; RISK; ATHEROSCLEROSIS; REDISTRIBUTION; INFLAMMATION; MONOCYTE; CANCER; COUNT;
D O I
10.3389/fcvm.2021.705862
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: The present study aimed to investigate the prognostic role of derived neutrophil-to-lymphocyte ratio (dNLR) in patients with coronary heart disease (CHD) after PCI. Methods: A total of 3,561 post-PCI patients with CHD were retrospectively enrolled in the CORFCHD-ZZ study from January 2013 to December 2017. The patients (3,462) were divided into three groups according to dNLR tertiles: the first tertile (dNLR < 1.36; n = 1,139), second tertile (1.36 >= dNLR < 1.96; n = 1,166), and third tertile(dNLR >= 1.96; n = 1,157). The mean follow-up time was 37.59 +/- 22.24 months. The primary endpoint was defined as mortality (including all-cause death and cardiac death), and the secondary endpoint was major adverse cardiovascular events (MACEs) and major adverse cardiovascular and cerebrovascular events (MACCEs). Results: There were 2,644 patients with acute coronary syndrome (ACS) and 838 patients with chronic coronary syndrome (CCS) in the present study. In the total population, the all-cause mortality (ACM) and cardiac mortality (CM) incidence was significantly higher in the third tertile than in the first tertile [hazard risk (HR) = 1.8 (95% CI: 1.2-2.8), p = 0.006 and HR = 2.1 (95% CI: 1.23-3.8), p = 0.009, respectively]. Multivariate Cox regression analyses suggested that compared with the patients in the first tertile than those in the third tertile, the risk of ACM was increased 1.763 times (HR = 1.763, 95% CI: 1.133-2.743, p = 0.012), and the risk of CM was increased 1.763 times (HR = 1.961, 95% CI: 1.083-3.550, p = 0.026) in the higher dNLR group during the long-term follow-up. In both ACS patients and CCS patients, there were significant differences among the three groups in the incidence of ACM in univariate analysis. We also found that the incidence of CM was significantly different among the three groups in CCS patients in both univariate analysis (HR = 3.541, 95% CI: 1.154-10.863, p = 0.027) and multivariate analysis (HR = 3.136, 95% CI: 1.015-9.690, p = 0.047). Conclusion: The present study suggested that dNLR is an independent and novel predictor of mortality in CHD patients who underwent PCI.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Association of the neutrophil-to-lymphocyte ratio and benign prostate hyperplasia
    Choi, S. M.
    Choi, J. H.
    Yoon, S.
    Jeh, S. U.
    Hwa, J. S.
    INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 : 66 - 66
  • [32] Neutrophil-to-lymphocyte ratio to predict prognosis in traumatic brain injury
    Alexiou, George A.
    Lianos, Georgios D.
    Zika, Jiolanda
    Alexiou, Eleutherios-Spyridon
    Voulgaris, Spyridon
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 56 : 341 - 341
  • [33] The importance of the neutrophil-to-lymphocyte ratio in the prognosis of glioma and its subtypes
    Linhares, Paulo
    Ferreira, Axel
    Vaz, Rui
    CNS NEUROSCIENCE & THERAPEUTICS, 2020, 26 (03) : 394 - 395
  • [34] The trend of neutrophil-to-lymphocyte ratio as a predictor of prognosis to nasopharyngeal carcinoma
    Yang, P.
    Zhao, Y.
    Mohamed, A.
    Liang, H.
    Chen, C.
    Xu, Y.
    Nantavithya, C.
    Kannarunimit, D.
    Shi, Y.
    Wang, H.
    Jin, H.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S368 - S368
  • [35] Neutrophil-to-lymphocyte ratio as a biomarker for prognosis in localized colorectal carcinoma
    Chic, N.
    Bruixola, G.
    Reig, O.
    Diaz-Beveridge, R.
    Buxo, E.
    Pineda, E.
    Prat, A.
    Aparicio, J.
    Maurel, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [36] Association analysis of dopaminergic degeneration and the neutrophil-to-lymphocyte ratio in Parkinson's disease
    Zhang, Fengjiao
    Chen, Bin
    Ren, Wenhua
    Yan, Yayun
    Zheng, Xiaoqi
    Jin, Shuxian
    Chang, Ying
    FRONTIERS IN AGING NEUROSCIENCE, 2024, 16
  • [37] Association of Neutrophil-to-Lymphocyte Ratio with Atherosclerotic Cardiovascular Disease and Kidney Outcomes in CKD
    Mahalwar, Gauranga
    Chen Zhengyi
    Horwitz, Edward J.
    Taliercio, Jonathan J.
    Rahman, Mahboob
    Dobre, Mirela A.
    Brateanu, Andrei
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [38] Neutrophil-to-lymphocyte ratio as an indicator of prognosis in patients with pancreatic cancer
    Kawada, Tomoyuki
    HPB, 2019, 21 (12) : 1791 - 1791
  • [39] Neutrophil-to-lymphocyte ratio predicts prognosis after neoadjuvant chemotherapy and resection of intrahepatic cholangiocarcinoma
    Omichi, Kiyohiko
    Cloyd, Jordan M.
    Yamashita, Suguru
    Tzeng, Ching-Wei D.
    Conrad, Claudius
    Chun, Yun Shin
    Aloia, Thomas A.
    Vauthey, Jean-Nicolas
    SURGERY, 2017, 162 (04) : 752 - 765
  • [40] Association between platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio with disease activity in Takayasu arteritis patients
    李治琴
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (04) : 214 - 215